Efficacy capture with unique high sensitivity

multiplex immunoassay technology

Aeirtec provides a modular integrated research collaborative activity of (1) unique high sensitivity multiplex ELISA biomarker measurement (patent pending), (2) custom marker panel design and assay validation, and (3) data interpretation through biostatistics.

This collaborative contribution is conducted according to the principles of GLP and ISO 17025:2005 compliance in conjunction with internal and external independent Quality Assurance.

Aeirtec is a CRO focused on provision of a unique high sensitivity marker assay technology in clinical studies

Custom Marker Panels In ELISA Multiplex Collaborations

Data Interpretation Through Biostatistics

The panel assays are validated prior to study sample analysis. Each marker assay conducted on samples is accompanied by measurements of lower and upper limits of quantification (LLOQ and ULOQ).